Our internal funding scheme supports large scale, collaborative clinical research and translational research in chronic liver disease.
Funding from EU's research and innovation initiatives supports our coordination and participation in multidisciplinary, patient-centered projects, with the goal of improving liver patient care and making a significant economic and societal impact.
We facilitate chronic liver disease research through ancillary studies led by independent researchers and managed by the applicant's home institution.
Private companies in the pharma and biotechnological sector fund clinical trials aimed at testing novel therapeutic interventions for chronic liver disease with the potential to improve patient outcomes.
We collaborate with leading tertiary care centers and university hospitals across the world.
Find out more about our partners across sectors.
Find out more about our research infrastructure and tools
